Laboratory Medicine ›› 2020, Vol. 35 ›› Issue (5): 508-510.DOI: 10.3969/j.issn.1673-8640.2020.05.025
Previous Articles Next Articles
Received:2020-03-30
Online:2020-05-30
Published:2020-06-17
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2020.05.025
| [1] | 朱耐伟,赵平,戚中田. 2019新型冠状病毒肺炎治疗研究现状[J]. 中华微生物学和免疫学杂志,2020,40(1):7-10. |
| [2] | 杨欣颖,缪从良,晋梦迪,等. 2019年新型冠状病毒肺炎的研究现状与进展[J]. 中华危重病急救医学,2020,32(2):E006. |
| [3] | FUKUYAMA S,KAWAOKA Y.The pathogenesis of influenza virus infections:the contributions of virus and host factors[J]. Curr Opin Immunol,2011,23(4):481-486. |
| [4] | METERSKY M L,MASTERTON R G,LODE H,et al.Epidemiology,microbiology,and treatment considerations for bacterial pneumonia complicating influenza[J]. Int J Infect Dis,2012,16(5):e321-e331. |
| [5] | OLIVEIRA L V N,COSTA M C,MAGALHÃES T F F,et al. Influenza A virus as a predisposing factor for cryptococcosis[J]. Front Cell Infect Microbiol,2017,7:419. |
| [6] | 赵虎. 深部真菌的耐药性及其耐药机制研究[J]. 检验医学,2016,31(9):735-738. |
| [7] | MITCHELL T G,PERFECT J R.Cryptococcosis in the era of AIDS-100 yearsafter the discovery of Cryptococcus neoformans[J]. Clin Microbiol Rev,1995,8(4):515-548. |
| [8] | 卢洪洲,钱雪琴,徐和平. 医学真菌检验与图解[M]. 上海:上海科学技术出版社,2018. |
| [9] | 刘茜,王荣帅,屈国强,等. 新型冠状病毒肺炎死亡尸体系统解剖大体观察报告[J]. 法医学杂志,2020,36(1):21-23. |
| [10] | 中华人民共和国国家卫生和计划生育委员会. WS/T 503—2017 临床微生物实验室血培养操作规范[S]. 2017. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
